{"id":3636,"date":"2025-10-20T11:51:57","date_gmt":"2025-10-20T15:51:57","guid":{"rendered":"https:\/\/halopharma.com\/?p=3636"},"modified":"2025-12-03T15:38:15","modified_gmt":"2025-12-03T20:38:15","slug":"halo-pharma-names-laurent-malgouyres-site-director-for-mirabel-canada-facility","status":"publish","type":"post","link":"https:\/\/halopharma.com\/fr\/halo-pharma-names-laurent-malgouyres-site-director-for-mirabel-canada-facility\/","title":{"rendered":"Halo Pharma nomme Laurent Malgouyres directeur du site de Mirabel, au Canada."},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"3636\" class=\"elementor elementor-3636\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-793f20ed e-flex e-con-boxed e-con e-parent\" data-id=\"793f20ed\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-263ebe1 custom-post-subhead e-flex e-con-boxed e-con e-parent\" data-id=\"263ebe1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-27b0f49 elementor-widget elementor-widget-text-editor\" data-id=\"27b0f49\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>Whippany, NJ \u2013 October 14, 2025<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-19f5d75 custom-post-subhead e-flex e-con-boxed e-con e-parent\" data-id=\"19f5d75\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b527b42 elementor-widget elementor-widget-text-editor\" data-id=\"b527b42\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul>\n<li><em>Malgouyres joins Halo with over 14 years of operational experience in the pharmaceutical industry<\/em><\/li>\n<li><em>As site director, he will oversee the operations of the Halo Mirabel cGMP manufacturing site<\/em><\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-514c3c3e e-flex e-con-boxed e-con e-parent\" data-id=\"514c3c3e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-25314274 elementor-widget elementor-widget-text-editor\" data-id=\"25314274\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><\/p>\n<p>Halo Pharma, a leading CDMO specializing in pharmaceutical development and manufacturing services, has appointed Laurent Malgouyres as Site Director for its cGMP facility in Mirabel, Quebec, Canada. In his new role, Malgouyres will oversee production, quality, and overall site performance.<\/p>\n<p>Malgouyres has worked in the pharmaceutical industry for over 14 years, most recently serving as Vice President of Operations at Omega Laboratories\/Juno Pharmaceuticals in Canada. His previous work leadership roles include positions at Pharmascience, where he managed FDA- and Health Canada-approved sites that employed more than 200 people. Throughout his career, he has successfully led initiatives to increase production capacity, implement operational efficiency processes, and execute major capital investment projects.<\/p>\n<p>\u201cLaurent has a track record of establishing autonomous, high-performing teams while fostering a culture of operational excellence, continuous improvement, and human development that align with our core beliefs and objectives at Halo Pharma,\u201d says Lee Karras, CEO of Noramco, parent company of Halo Pharma. \u201cLaurent\u2019s experience and vision will be instrumental as we continue to strengthen our manufacturing capabilities and position Halo Pharma for long-term growth.\u201d<\/p>\n<p>Halo Pharma\u2019s Mirabel site opened more than 40 years ago and has served as a center of pharmaceutical development and manufacturing excellence, offering solid dose, bulk powder, oral liquid, and suppository development and manufacturing.<\/p>\n<p>\u201cI\u2019m honored to join Halo Pharma and lead the talented team in Mirabel,\u201d said Malgouyres. \u201cThe site has a strong legacy of quality and innovation, and I look forward to building on that foundation as we continue to enhance our capabilities and deliver value to our customers.\u201d<\/p>\n<p>For more information about Halo Pharma, visit <a href=\"https:\/\/halopharma.com\/fr\/\">https:\/\/halopharma.com<\/a>.<\/p>\n<p>About Halo Pharma<br \/>Halo Pharma is a rapidly growing contract development and manufacturing organization (CDMO) that provides scientific and development expertise, as well as a wide spectrum of manufacturing services, from its locations in Whippany, New Jersey, USA and Montreal, Quebec, Canada to its international client base. Halo offers fully integrated capabilities in a variety of dosage forms including tablets, capsules, powders, liquids, creams, sterile and non-sterile ointments and suppositories. The company is registered to work with any of these dosages in the CI-CV DEA designations. Halo Pharma\u2019s capabilities in the areas of tech transfer, process and product development, production, scale-up\/validation and analytical method development allow us to partner with clients from development through commercialization or at any point along the way. For more information, please contact <a href=\"mailto:services@halopharma.com\">services@halopharma.com<\/a>.<\/p>\n<p><strong>Media Contact<\/strong><br \/>Resource Advantage<br \/>Dan Green<br \/><a href=\"mailto:dgreen@resourceadvantage.com\">dgreen@resourceadvantage.com<\/a><\/p>\n<p><strong>Company Contact<\/strong><br \/>Halo Pharma &amp; Woodstock Sterile Solutions<br \/>Stacy London<br \/><a href=\"mailto:Stacy.london@wssterile.com\">Stacy.london@wssterile.com<\/a><\/p>\n<p><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Whippany, NJ \u2013 October 14, 2025 Malgouyres joins Halo with over 14 years of operational experience in the pharmaceutical industry As site director, he will oversee the operations of the Halo Mirabel cGMP manufacturing site Halo Pharma, a leading CDMO specializing in pharmaceutical development and manufacturing services, has appointed Laurent Malgouyres as Site Director for [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":3638,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-3636","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3636"}],"version-history":[{"count":21,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3636\/revisions"}],"predecessor-version":[{"id":3708,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3636\/revisions\/3708"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/media\/3638"}],"wp:attachment":[{"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}